Safety of Tonsillectomy and/or Adenoidectomy in Pediatric Patients with Prolonged Activated Partial Thromboplastin Time and Factor XII Deficiency
DOI: https://doi.org/10.2147/jir.s462617
IF: 4.5
2024-05-31
Journal of Inflammation Research
Abstract:Jun Du, 1 Qing-long Gu, 1 Ying-xia Lu, 1 Lei Zhang, 2 Xiao-jun Zhan, 1 Zhan Wang 1 1 Department of Otolaryngology, Head and Neck Surgery, Children's Hospital Capital Institute of Pediatrics, Beijing, 100000, People's Republic of China; 2 Department of Hematopathology, Children's Hospital Capital Institute of Pediatrics, Beijing, 100000, People's Republic of China Correspondence: Qing-long Gu, Department of Otolaryngology, Head and Neck Surgery, Children's Hospital Capital Institute of Pediatrics, No. 2 Yabao Road, Chaoyang District, Beijing, 100020, People's Republic of China, Tel +86-13810091816, Email Objective: To evaluate the safety and feasibility of tonsillectomy and/or adenoidectomy (T&A) in pediatric patients with prolonged activated partial thromboplastin time (APTT) and coagulation factor deficiency. Methods: A prospective study was admitted to the children undergoing T&A at our institution between October 2019 and January 2020, specifically focusing on preoperative coagulation function. Within this group, we identified 5 patients exhibiting prolonged APTT and coagulation factor deficiencies, constituting the experimental group, and 10 patients matched by gender and age with normal blood coagulation function were selected as the control group. Comparative analyses between the two groups were conducted, focusing on surgical duration, intraoperative bleeding volume, duration of hospital stay, and postoperative complications such as active bleeding across the groups. At the six-month postoperative mark, a reassessment of coagulation functions and factor assays was conducted within the experimental group. Results: No statistically significant differences were discovered in terms of surgical duration or bleeding volume when comparing the experimental subgroups with their respective control counterparts. Furthermore, there were no incidences of postoperative active bleeding observed in any of the groups. Notably, postoperative APTT values (32.7 ± 1.7s) exhibited a significant disparity compared to preoperative levels (43.7 ± 1.8s, p < 0.01). Coagulation factors demonstrated normalization, evidenced by a significant difference in postoperative Factor XII levels (40.2 ± 5.4%) compared to preoperative levels (63.1 ± 5.9%, p < 0.01). Conclusion: Prolonged APTT with FXII factor deficiency does not show a significant bleeding tendency and is not a contraindication for T&A surgery. Post T&A surgery, children with abnormal coagulation function and deficient clotting factors show significant improvement compared to pre-surgery. It is important to consider that chronic inflammation in adenoids and tonsils may contribute to the prolongation of APTT and the manifestation of Factor XII deficiency. Keywords: adenoidectomy, children, factor XII deficiency, prolonged APTT, tonsillectomy Obstructive sleep apnea (OSA) is a respiratory disorder characterized by the partial or total collapse of the upper airways with intermittent hypoxia, a chronic systemic inflammatory state, and an increased cardiovascular risk. 1 It also has an effect on adult OSA. 2 Tonsillectomy and adenoidectomy (T&A) rank among the most frequently performed surgical procedures 3,4 in children. The primary complications associated with these interventions primarily revolve around intraoperative and postoperative bleeding. The reported bleeding rate 5 for adenoidectomy is approximately 0.5%, while for tonsillectomy, it ranges from 0.5% to 5%. 6–8 Postoperative hemorrhage can lead to prolonged hospitalization, necessitate subsequent surgical interventions, and in severe instances, pose life-threatening consequences. The estimated mortality rate for tonsillectomy in the UK falls within the range of 1 in 10,000 to 1 in 28,700. 9 Existing research underscores a substantially elevated post-tonsillectomy bleeding rate of 15–53% in children with hemorrhagic disorders, in contrast to those with normal coagulation profiles. 10–12 Consequently, safely conducting T&A in children with coagulation function abnormalities, particularly those with mild coagulation disorders, presents a significant clinical challenge. The identification of optimal management strategies for such cases is imperative. This article presents a prospective analysis of clinical data derived from five children with coagulation function abnormalities who recently underwent T&A in our department, highlighting the critical importance of sensitive preoperative assessments and effective postoperative management. Between October 2019 and January 2020, an assessment was conducted on 368 children scheduled for T&A at the Departme -Abstract Truncated-
immunology